Cargando…
Prostate cancer biomarkers: Are we hitting the mark?
PURPOSE: Localised prostate cancer diagnosis and management is increasingly complex due to its heterogeneous progression and prognostic subgroups. Pitfalls in current screening and diagnosis have prompted the search for accurate and invasive molecular and genetic biomarkers for prostate cancer. Such...
Autores principales: | McGrath, Shannon, Christidis, Daniel, Perera, Marlon, Hong, Sung Kyu, Manning, Todd, Vela, Ian, Lawrentschuk, Nathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Pacific Prostate Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153438/ https://www.ncbi.nlm.nih.gov/pubmed/27995111 http://dx.doi.org/10.1016/j.prnil.2016.07.002 |
Ejemplares similares
-
Minimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies
por: Christidis, Daniel, et al.
Publicado: (2017) -
Prostate cancer screening with prostate-specific antigen: A guide to the guidelines
por: Cabarkapa, Sonja, et al.
Publicado: (2016) -
Trends in percutaneous renal biopsy: The evolving diagnostic pathway for the small renal mass
por: Perera, Marlon, et al.
Publicado: (2018) -
Incidental prostate cancer in transurethral resection of prostate specimens in men aged up to 65 years
por: Perera, Marlon, et al.
Publicado: (2016) -
Mesenteric metastases from mature teratoma of the testis: A case report
por: Loh, Zoe, et al.
Publicado: (2020)